Viewing data from:

ESGIC

ANDA

ACETAMINOPHEN; BUTALBITAL; CAFFEINE | A089660 | FOREST PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Esgic (2023)

Total Spending

$94K

Total Claims

224

Beneficiaries

Avg Cost/Unit

$5.43

Spending Trend

$289K(2019)→$221K(2020)→$210K(2021)→$157K(2022)→$94K(2023)

YoY Change:+5.2%

5yr CAGR:+1.9%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 325MG;50MG;40MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 23, 1988

No patent or exclusivity listings for this strength.